These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 21457304

  • 1. N-terminal-pro-brain natriuretic peptide: a guide for early targeted indomethacin therapy for patent ductus arteriosus in preterm Infants.
    Nuntnarumit P, Chongkongkiat P, Khositseth A.
    Acta Paediatr; 2011 Sep; 100(9):1217-21. PubMed ID: 21457304
    [Abstract] [Full Text] [Related]

  • 2. N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus.
    Farombi-Oghuvbu I, Matthews T, Mayne PD, Guerin H, Corcoran JD.
    Arch Dis Child Fetal Neonatal Ed; 2008 Jul; 93(4):F257-60. PubMed ID: 18218660
    [Abstract] [Full Text] [Related]

  • 3. N-terminal probrain natriuretic peptide and patent ductus arteriosus in preterm infants.
    Nuntnarumit P, Khositseth A, Thanomsingh P.
    J Perinatol; 2009 Feb; 29(2):137-42. PubMed ID: 19020527
    [Abstract] [Full Text] [Related]

  • 4. [Value of amino-terminal pro-brain natriuretic peptide as a predictive marker of symptomatic patent ductus arteriosus in preterm infants].
    Lu KS, Guo XL, Lv JF, Huang SL, Yang CH, Zou ZH, Chen ZJ, Lai CH, Yang BY.
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Nov; 17(11):1160-4. PubMed ID: 26575871
    [Abstract] [Full Text] [Related]

  • 5. Role of plasma B-type natriuretic peptide in screening for hemodynamically significant patent ductus arteriosus in preterm neonates.
    Sanjeev S, Pettersen M, Lua J, Thomas R, Shankaran S, L'Ecuyer T.
    J Perinatol; 2005 Nov; 25(11):709-13. PubMed ID: 16222347
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Patent ductus arteriosus, systemic NT-proBNP concentrations and development of bronchopulmonary dysplasia in very preterm infants: retrospective data analysis from a randomized controlled trial.
    Potsiurko S, Dobryanskyy D, Sekretar L.
    BMC Pediatr; 2021 Jun 19; 21(1):286. PubMed ID: 34147090
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Early NT-proBNP levels as a screening tool for the detection of hemodynamically significant patent ductus arteriosus during the first week of life in very low birth weight infants.
    Rodriguez-Blanco S, Oulego-Erroz I, Gautreaux-Minaya S, Perez-Muñuzuri A, Couce-Pico ML.
    J Perinatol; 2018 Jul 19; 38(7):881-888. PubMed ID: 29785059
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Diagnosing significant PDA using natriuretic peptides in preterm neonates: a systematic review.
    Kulkarni M, Gokulakrishnan G, Price J, Fernandes CJ, Leeflang M, Pammi M.
    Pediatrics; 2015 Feb 19; 135(2):e510-25. PubMed ID: 25601976
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. N-Terminal Pro-B Type Natriuretic Peptide as a Marker of Bronchopulmonary Dysplasia or Death in Very Preterm Neonates: A Cohort Study.
    Sellmer A, Hjortdal VE, Bjerre JV, Schmidt MR, McNamara PJ, Bech BH, Henriksen TB.
    PLoS One; 2015 Feb 19; 10(10):e0140079. PubMed ID: 26452045
    [Abstract] [Full Text] [Related]

  • 19. N-terminal-probrain natriuretic peptide as a biomarker of moderate to severe bronchopulmonary dysplasia in preterm infants: A prospective observational study.
    Rodríguez-Blanco S, Oulego-Erroz I, Alonso-Quintela P, Terroba-Seara S, Jiménez-González A, Palau-Benavides M.
    Pediatr Pulmonol; 2018 Aug 19; 53(8):1073-1081. PubMed ID: 29790673
    [Abstract] [Full Text] [Related]

  • 20. Early N-terminal pro-brain natriuretic peptide measurements predict clinically significant ductus arteriosus in preterm infants.
    Ramakrishnan S, Heung YM, Round J, Morris TP, Collinson P, Williams AF.
    Acta Paediatr; 2009 Aug 19; 98(8):1254-9. PubMed ID: 19432837
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.